Credence

Credence MedSystems, Inc.

Menlo Park, United States · Founded 2011 · $67.6M raised

Employees
11–50
Founded
2011
Business Model
B2B
Total Funding
$67.6M
Last Round
$12.7M Series DDec 2024
Rounds
4

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

About

Credence MedSystems is a Menlo Park, California-based medical device company developing injectable drug delivery devices for biopharma customers. Its Innovation Without Change® strategy enables drug manufacturers to differentiate their products through enhanced delivery systems while preserving existing validated processes, sourcing preferences, and components. It serves pharmaceutical and biotechnology manufacturers.

Summary

Credence is a Healthcare company based in Menlo Park, United States, founded in 2011. It has raised $67.6M in total across 4 rounds, most recently a $12.7M Series D round in Dec 2024. Investors include Novartis Venture Fund and Molex Ventures.

Tech & App Stack

5 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series DSeries DDec 2024
$12.7M

Sign up to see all 4 events

Funding: Seed through Series D. Amounts, valuations, and investors where available.

Investors

Similar Companies

Shields Health Solutions

The nation's first company to integrate specialty pharmacies into hospitals and health systems, h...

United StatesHealthcare, Drug Discovery
Corporate RoundTotal funding$3.5BSep 2025
AsymchemIPO

Asymchem is a pharmaceutical CDMO providing R&D, chemistry, manufacturing, and control services t...

Tianjin, China5001–10000Biotech, Drug Discovery
Private EquityTotal funding$2.3BFeb 2020
PHC

PHC is a leading provider of diabetes monitoring systems, specialized laboratory equipment, and c...

Minato, Japan5001–10000Healthcare, Life Sciences
Private EquityTotal funding$1.9BMar 2021
Abogen Biosciences

Abogen Biosciences develops RNA therapeutics using integrated mRNA design, lipid nanoparticle del...

Suzhou, China201–500Biotech, Drug Discovery
Extension RoundTotal funding$1.2BNov 2021
Eikon TherapeuticsIPO

Late-stage biopharma using single-molecule tracking, AI, and engineering to discover and develop ...

Hayward, United States201–500Artificial Intelligence, Biotech
Series DTotal funding$1.1BFeb 2025
Xaira Therapeutics

Xaira Therapeutics is an integrated biotechnology company driving advances in artificial intellig...

South San Francisco, United States51–200Artificial Intelligence, Biotech
Series ATotal funding$1.0BApr 2024

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Credence on Indexed.vc
<a href="https://indexed.vc/companies/credence"><img src="https://indexed.vc/api/badge/company/credence" alt="Credence on Indexed.vc" width="260" height="76" /></a>